This page provides centralized resources for those seeking information about the ROADS clinical trial. Explore the latest announcements, peer-reviewed clinical publications, educational materials, messaging resources, and multimedia assets related to the trial and its findings.
Press Releases
Key announcements and milestones related to the ROADS clinical trial
ROADS Phase 3 Clinical Trial Data Presented at ASCO26 Show GammaTile® Provides Superior Tumor Control Leading to Patients Living Longer Without Recurrence Compared to Standard of Care in Newly Diagnosed Operable Brain Metastases
ASCO: Tile-Based Radiation Therapy Lowers Risk of Recurrence in Brain Metastases (The University of Texas MD Anderson Cancer Center)
Implanted Tile-Based Radiation Outperforms Stereotactic Radiotherapy for Treatment of Brain Metastases (ASCO)
Clinical Data
Abstracts, presentations and publications related to the ROADS clinical trial
ROADS Phase 3 Results Abstract Presented at ASCO® 2026
Final results of a randomized, controlled, phase 3 trial comparing resection and post-operative stereotactic radiation versus resection and cesium-131 tile-based radiation for treatment of newly diagnosed brain metastases.
Media Inquiries
For media inquiries and GammaTile Key Opinion Leader (KOL) interviews:
